These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 19631714

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.
    Aoki E, Yano R, Yokoyama H, Kato H, Araki T.
    Exp Mol Pathol; 2009 Feb; 86(1):57-64. PubMed ID: 19027004
    [Abstract] [Full Text] [Related]

  • 23. Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.
    Drolet RE, Behrouz B, Lookingland KJ, Goudreau JL.
    Neurotoxicology; 2004 Sep; 25(5):761-9. PubMed ID: 15288507
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Evidence for a dissociation between MPTP toxicity and tyrosinase activity based on congenic mouse strain susceptibility.
    Hofele K, Sedelis M, Auburger GW, Morgan S, Huston JP, Schwarting RK.
    Exp Neurol; 2001 Mar; 168(1):116-22. PubMed ID: 11170726
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse basal ganglia.
    Fisher BE, Petzinger GM, Nixon K, Hogg E, Bremmer S, Meshul CK, Jakowec MW.
    J Neurosci Res; 2004 Aug 01; 77(3):378-90. PubMed ID: 15248294
    [Abstract] [Full Text] [Related]

  • 29. Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
    Araki T, Muramatsu Y, Tanaka K, Matsubara M, Imai Y.
    Neurosci Lett; 2001 Oct 12; 312(1):50-4. PubMed ID: 11578843
    [Abstract] [Full Text] [Related]

  • 30. Differential effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the olfactory bulb and the striatum in mice.
    Mitsumoto Y, Mori A, Ohashi S, Nakai M, Moriizumi T.
    Neurosci Res; 2005 Jan 12; 51(1):111-5. PubMed ID: 15596247
    [Abstract] [Full Text] [Related]

  • 31. Manganese does not alter the severe neurotoxicity of MPTP.
    Baek SY, Kim YH, Oh SO, Lee CR, Yoo CI, Lee JH, Lee H, Sim CS, Park J, Kim JW, Yoon CS, Kim Y.
    Hum Exp Toxicol; 2007 Mar 12; 26(3):203-11. PubMed ID: 17439923
    [Abstract] [Full Text] [Related]

  • 32. The impact of gender and estrogen on striatal dopaminergic neurotoxicity.
    Miller DB, Ali SF, O'Callaghan JP, Laws SC.
    Ann N Y Acad Sci; 1998 May 30; 844():153-65. PubMed ID: 9668673
    [Abstract] [Full Text] [Related]

  • 33. The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease.
    Litim N, Bourque M, Al Sweidi S, Morissette M, Di Paolo T.
    Neuropharmacology; 2015 Oct 30; 97():86-94. PubMed ID: 26006269
    [Abstract] [Full Text] [Related]

  • 34. Effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system of C57/B1 mice.
    Dluzen DE.
    Brain Res; 1996 Apr 09; 715(1-2):113-8. PubMed ID: 8739629
    [Abstract] [Full Text] [Related]

  • 35. Age- and sex-differences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Joniec I, Ciesielska A, Kurkowska-Jastrzebska I, Przybylkowski A, Czlonkowska A, Czlonkowski A.
    Brain Res; 2009 Mar 19; 1261():7-19. PubMed ID: 19401171
    [Abstract] [Full Text] [Related]

  • 36. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
    Sathiya S, Ranju V, Kalaivani P, Priya RJ, Sumathy H, Sunil AG, Babu CS.
    Neuropharmacology; 2013 Oct 19; 73():98-110. PubMed ID: 23747572
    [Abstract] [Full Text] [Related]

  • 37. Pyrethroid and organophosphate insecticide exposure in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease: an immunohistochemical analysis of tyrosine hydroxylase and glial fibrillary acidic protein in dorsolateral striatum.
    Dodd CA, Klein BG.
    Toxicol Ind Health; 2009 Feb 19; 25(1):25-39. PubMed ID: 19318502
    [Abstract] [Full Text] [Related]

  • 38. Neuronal and astroglial responses to the serotonin and norepinephrine neurotoxin: 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine.
    Luellen BA, Miller DB, Chisnell AC, Murphy DL, O'Callaghan JP, Andrews AM.
    J Pharmacol Exp Ther; 2003 Dec 19; 307(3):923-31. PubMed ID: 14561848
    [Abstract] [Full Text] [Related]

  • 39. Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/bl and CD-1 mice.
    Muthane U, Ramsay KA, Jiang H, Jackson-Lewis V, Donaldson D, Fernando S, Ferreira M, Przedborski S.
    Exp Neurol; 1994 Apr 19; 126(2):195-204. PubMed ID: 7925820
    [Abstract] [Full Text] [Related]

  • 40. Protocatechuic acid inhibits neurotoxicity induced by MPTP in vivo.
    Zhang HN, An CN, Zhang HN, Pu XP.
    Neurosci Lett; 2010 Apr 26; 474(2):99-103. PubMed ID: 20227465
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.